Panel: Court Erred In Admitting, Barring Evidence At Securities Fraud Trial

(February 11, 2016, 4:08 PM EST) -- NEW ORLEANS — A federal district court abused its discretion in allowing certain evidence and not allowing other evidence to be shown in a securities fraud criminal action against former executive officers of a medical device company, a Fifth Circuit U.S. Court of Appeals panel ruled Jan. 25 in vacating and remanding the action to the district court for a new trial (United States of America v. Michael Gluk, et al., No. 14-51012, 5th Cir.).

(Opinion available. Document #57-160216-066Z.)

ArthroCare Corp. CEO Michael Baker and Chief...
To view the full article, register now.